AzTrials
AzTrials

FibromyalgiaNCT07734662

High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia

A study testing Preferred-Intensity Resistance Training Group (PIG) and High-Intensity Resistance Training Group (HIG) in people with Fibromyalgia, run by University of the State of Santa Catarina at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized crossover clinical trial aims to verify and compare the effects of high-intensity (HIG) and preferred-intensity (PIG) resistance training on the health of women with fibromyalgia (FM). Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Fibromyalgia
What is being tested?
Preferred-Intensity Resistance Training Group (PIG) and High-Intensity Resistance Training Group (HIG)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteBrazil
Study dates
1 Jul 2024to 15 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Provision of signed informed consent to participate in the study.
  • Female participants aged 18 years or older.
  • Confirmed clinical diagnosis of fibromyalgia documented by a medical report.
  • Not currently participating in any regular physical activity involving strength or resistance training.

Who cannot join

  • Presence of physical or cognitive conditions that impair the execution of the prescribed exercises.
  • Pregnancy.
  • Medical contraindication to physical exercise.
  • Engagement in physical activities such as resistance training, Pilates, swimming, calisthenics, yoga, or martial arts.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Centro de Ciências da Saúde e do Esporte / Universidade do Estado de Santa Catarina

    Florianópolis, Santa Catarina, 88080-350

Other trials in Brazil

About this study

Official title: Effects of High-Intensity Versus Preferred-Intensity Resistance Training in the Treatment of Women With Fibromyalgia: A Randomized Crossover Clinical Trial

This randomized crossover clinical trial aims to verify and compare the effects of high-intensity (HIG) and preferred-intensity (PIG) resistance training on the health of women with fibromyalgia (FM). Secondary objectives include verifying differences after 4, 8, and 16 sessions, as well as evaluating the proportion of participants who achieve the minimal clinically important difference in the disease impact/severity outcome.

Patients included in the study will be randomized into two groups: HIG and PIG. Sixteen training sessions will be conducted twice a week, with each session lasting approximately 60 minutes. Subsequently, patients will undergo a minimum 8-week washout period (detraining) and will then be allocated to the other intervention group.

The primary outcome is disease impact evaluated using the Revised Fibromyalgia Impact Questionnaire (FIQR). Secondary outcomes include mood states evaluated by the Brunel Mood Scale (BRUMS), sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI), anxiety levels evaluated with the Beck Anxiety Inventory (BAI), and depression levels evaluated with the Beck Depression Inventory (BDI). Attendance and absence data will also be collected, as well as information regarding program discontinuation.

Conditions
Fibromyalgia
Being tested
Preferred-Intensity Resistance Training Group (PIG), High-Intensity Resistance Training Group (HIG)
Keywords
Mental Health
Medical subject headings
Fibromyalgia, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Preferred-Intensity Resistance Training Group (PIG)Device

    Also called Exercise

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Prior to the intervention, participants complete 3 familiarization sessions without intensity control to learn proper exercise execution and facility equipment. Each session includes a low-load warm-up (1 lower-body and 2 upper-body exercises), main part of the session (chest press, seated cable row, squat, leg press, shoulder press, and standing calf raise), and 10 minutes of static stretching cooldown. Participants perform 3 sets of 8-12 repetitions with 1-2 minutes of rest between sets. Load selection is based on the participant's perceived capacity, with instructions that the weight may lead to concentric failure. Load progression occurs when exercises are performed with proper technique and the participant requests an increase; all loads are continuously logged.

  • High-Intensity Resistance Training Group (HIG)Device

    Also called Exercise

    Participants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Prior to the intervention, participants complete 3 familiarization sessions without intensity control to learn proper exercise execution and facility equipment. Each session includes a low-load warm-up (1 lower-body and 2 upper-body exercises), themain part of the sessi (chest press, seated cable row, squat, leg press, shoulder press, and standing calf raise), and 10 minutes of static stretching cooldown. Participants perform 4 sets of 6 repetitions with 2 minutes of rest between sets, encouraged to reach concentric failure on the final set.Load increases by 10%-20% following proper execution across two consecutive sessions; all loads are continuously logged.

Study groups in NCT07734662
Study groupRoleWhat they receive
High-intensity resistance training(HIG)ExperimentalParticipants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Sessions take place in an academic exercise facility under the supervision of qualified physical therapists, exercise physiologists, or trained undergraduate students. Temporary adaptations (e.g., load reduction, modified range of motion, bench angle adjustments, or box squats) are applied as needed for fibromyalgia symptoms to support progression toward standard execution. Adverse events, attendance, and reasons for missed sessions or dropouts are systematically monitored and recorded. Dosage: 4 sets of 6 repetitions with 2 minutes of rest between sets. Participants are encouraged to reach concentric failure on the last set. Load: Load increases by 10% to 20% after proper execution for two consecutive sessions, under supervisor guidance.
Receives: Device: High-Intensity Resistance Training Group (HIG)
Preferred-intensity resistance training (PIG)ExperimentalParticipants complete an 8-week supervised resistance training program consisting of 2 weekly 60-minute sessions (up to 16 sessions total, with flexibility to reschedule missed sessions due to clinical reasons). Sessions take place in an academic exercise facility under the supervision of qualified physical therapists, exercise physiologists, or trained undergraduate students. Temporary adaptations (e.g., load reduction, modified range of motion, bench angle adjustments, or box squats) are applied as needed for fibromyalgia symptoms to support progression toward standard execution. Adverse events, attendance, and reasons for missed sessions or dropouts are systematically monitored and recorded. Dosage: 3 sets of 8-12 repetitions with 1 to 2 minutes of rest between sets. Load : Participants self-select the load based on their perceived capacity, with the suggestion that it could lead to concentric failure. Load increases when the participant executes the movement correctly and requests
Receives: Device: Preferred-Intensity Resistance Training Group (PIG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Severity and impact of fibromyalgia

    The Revised Fibromyalgia Impact Questionnaire (FIQR) evaluates the impact of fibromyalgia on patients' quality of life over the preceding 7 days (Lupi et al., 2017). The instrument assesses symptoms and daily difficulties using a 0-to-10 numerical rating scale, where higher scores indicate greater disease impact. The 21-item questionnaire yields a total score ranging from 0 to 100, composed of three subscales: Function (0-30), Overall Impact (0-20), and Symptoms (0-50). Total scores can also be classified into severity categories: 0-23 (remission), 24-40 (mild), 41-63 (moderate), 64-82 (severe), and ≥ 83 (very severe) (Salaffi et al., 2021).

    Measured: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

Secondary outcomes (4)
  1. Mood States (BRUMS)

    Assessed using the Brunel Mood Scale (BRUMS), a 24-item questionnaire scored on a 5-point Likert scale from 0 (not at all) to 4 (extremely). It measures six subscales: Tension, Depression, Anger, Vigor, Fatigue, and Confusion. Each subscale score ranges from 0 to 16, with higher scores reflecting greater intensity of the respective mood state.

    Measured: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  2. Sleep Quality (PSQI)

    Assessed using the Pittsburgh Sleep Quality Index (PSQI), which evaluates sleep quality over the past week across seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Global scores range from 0 to 21, where values of five or higher indicate poor quality.

    Measured: Baseline, 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  3. Anxiety Levels (BAI)

    Assessed using the Beck Anxiety Inventory (BAI), a 21-item self-report questionnaire. Items are scored on a scale from 0 to 3, yielding a total score ranging from 0 to 63, where higher scores indicate higher levels of anxiety.

    Measured: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)

  4. Depression Levels (BDI)

    Assessed using the Beck Depression Inventory (BDI), a 21-item self-report questionnaire. Items are scored on a scale from 0 to 3, yielding a total score ranging from 0 to 63, where higher scores indicate higher levels of depressive symptoms.

    Measured: Baseline, and 8 weeks (after 16 sessions)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2026
  2. Study start1 Jul 2024
  3. Primary completion1 Dec 2025
  4. Study completion15 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
This is a randomized crossover clinical trial in which participants will be randomized to one of two sequences: performing high-intensity resistance training, followed by an 8-week washout period, and then performing preferred-intensity resistance training; or performing preferred-intensity resistance training, followed by an 8-week washout period, and then performing high-intensity resistance training. This study is conducted at a single center. Participants complete the questionnaires at baseline, after 4 sessions, after 8 sessions, and after 16 sessions.
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07734662
Sponsor's protocol ID
40877420.0.0000.0118
Other IDs
40877420.0.0000.0118
Status last verified
Jul 2026
First submitted
21 Jul 2026
Last updated
29 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Vilarino GT, Andreato LV, de Souza LC, Branco JHL, Andrade A. Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review. Clin Rheumatol. 2021 Nov;40(11):4417-4425. doi: 10.1007/s10067-021-05738-z. Epub 2021 May 14.

    PubMed 33987785
  • Vilarino GT, Branco JHL, de Souza LC, Andrade A. Effects of resistance training on the physical symptoms and functional capacity of patients with fibromyalgia: a systematic review and meta-analysis of randomized clinical trials. Ir J Med Sci. 2023 Aug;192(4):2001-2014. doi: 10.1007/s11845-022-03205-5. Epub 2022 Nov 3.

    PubMed 36326999

Questions about this trial

What is this clinical trial studying?

A study testing Preferred-Intensity Resistance Training Group (PIG) and High-Intensity Resistance Training Group (HIG) in people with Fibromyalgia, run by University of the State of Santa Catarina at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Severity and impact of fibromyalgia (time frame: Baseline, 2 weeks (4 sessions), 4 weeks (8 sessions), and 8 weeks (after 16 sessions)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07734662, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in